Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
The global market for Crude Heparin is estimated to increase from US$ 3665.8 million in 2021 to reach US$ 6057.2 million by 2028, exhibiting a CAGR of 7.4% during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Global key players of crude heparin include Bioiberica, Shenzhen Hepalink, Sanofi, etc. The top three players hold a share about 37%. The global crude heparin products are mainly produced in Europe and China, they occupied for a share over 50%. Asia-Pacific is the largest market, has a share about 57%, followed by North America and Europe, with share 21% and 18%, separately.
Report Coverage
This latest report provides a deep insight into the global Crude Heparin market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Crude Heparin market, with both quantitative and qualitative data, to help readers understand how the Crude Heparin market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Tons.
Market Segmentation:
The study segments the Crude Heparin market and forecasts the market size by Type (Pig Intestine Mucosa Heparin and Bovine Heparin and Others,), by Application (UFH and LMWH.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Pig Intestine Mucosa Heparin
Bovine Heparin and Others
Segmentation by application
UFH
LMWH
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Bioiberica
Shenzhen Hepalink
Sanofi
Nanjing King-friend
Fengrun Biological Technology
Aspen Oss
Hebei Changshan Biochemical
Changzhou Qianhong
Hepac (Darling Ingredients)
Huaian MDC Pharmaceutical
Yantai Dongcheng Biochemicals
Chapter Introduction
Chapter 1: Scope of Crude Heparin, Research Methodology, etc.
Chapter 2: Executive Summary, global Crude Heparin market size (sales and revenue) and CAGR, Crude Heparin market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Crude Heparin sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Crude Heparin sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Crude Heparin market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend, Fengrun Biological Technology, Aspen Oss, Hebei Changshan Biochemical, Changzhou Qianhong and Hepac (Darling Ingredients), etc.
Chapter 14: Research Findings and Conclusion